Combined Use of Duloxetine and Olanzapine in the Treatment of Urologic Chronic Pelvic Pain Syndromes Refractory to Conventional Treatment: A Case Report
10.9758/cpn.2018.16.1.122
- Author:
Bo BI
1
;
Liping SHAN
;
Die ZHOU
Author Information
1. Department of Psychiatry, First Affiliated Hospital, China Medical University, Shenyang, PR China. skiffinbb@163.com
- Publication Type:Case Report
- Keywords:
Bladder pain;
Painful urinary urgency;
Duloxetine;
Olanzapine;
Anxiety
- MeSH:
Anxiety;
Duloxetine Hydrochloride;
Humans;
Male;
Middle Aged;
Pelvic Pain;
Urinary Bladder
- From:Clinical Psychopharmacology and Neuroscience
2018;16(1):122-125
- CountryRepublic of Korea
- Language:English
-
Abstract:
Patients with urologic chronic pelvic pain syndromes (UCPPS) report interstitial cystitis/bladder pain syndrome and/or chronic prostatitis/chronic pelvic pain syndrome. The pathogenesis of these syndromes remains unclear and there is currently no standard treatment. UCPPS is, therefore, often misdiagnosed and its management is complex. The present case report involves a 62-year-old male patient with UCPPS whose main presentation is painful bladder filling and painful urgency refractory to conventional treatment with medication, which was successfully treated with the combined use of duloxetine and olanzapine. The combined use of duloxetine and olanzapine may become a new therapeutic option in the management of UCPPS.
